
#295 More or (Even) Less Certainty in EU Merger Control? The European Court of Justice Judgment in Illumina/GRAIL
Our Curious Amalgam
00:00
Navigating Uncertainty in EU Merger Regulation
This chapter examines the impact of the European Commission's revised Article 22 referral procedure on pharmaceutical mergers, emphasizing the resulting uncertainty for companies and legal practitioners. The discussion highlights the challenges posed by the Illumina/GRAIL case and the broader implications of recent shifts in merger control law within the EU.
Transcript
Play full episode